Natalizumab or Tysbari is a monoclonal antibody that treats multiple sclerosis and many of its courses such as clinically isolated syndrome, relapsing- remitted syndrome, and active secondary progressive disease. According to our textbook, monoclonal antibodies can be defined as “antibody molecules with a single specificity produced in vitro by lymphocytes that have been fused with a type of malignant myeloma cell. The product of fusing lymphocytes and myeloma cells is a hybridoma that receives the trait of proliferating and multiplying indefinitely from the myeloma cell and the specific antibody producing trait from the b cell. In the laboratory, scientists are able to isolate and harvest identical antibodies from the hybridomas that have the same constant and variable regions. Monoclonal antibodies provide a consistent base that facilitate the wide-spread and standardized use for tests that diagnose diseases and now antibiotics, such as natalizumab, that treat diseases.
Thee purpose of Tysbari is to limit the number of multiple sclerosis flares and to prevent the physical damage caused by MS from progressing quickly. Tysbari is administered intravenously ever 28 days, and the administering process takes two hours; one hour of infusion and an additional hour in the hospital to make sure you are not having a reaction to the infusion. According to this article, Tysbari works by preventing the white blood cells of the immune system from going into the brain and spinal chord. Tysbari prevents leukocytes from crossing the blood-brain barrier into the brain and spinal chord which leads to the detrimental nerve damaging effects of MS. According to this website, this monoclonal antibody is one of the recommended infused medications by the National Multiple Sclerosis Society.
According to the FDA, Tysbari is an immunosuppressant medication which can lead to some of its side effects. Some of the serious side effects of Tysbari include:
- Herpes Encephalitis or meningitis
- Liver damage which causes jaundice, nausea, vomiting, darkening of urine, feeling weak or tired
- Allergic reactions which cause hives, itching, trouble breathing, chest pain, dizziness, wheezing, chills, rash nausea, flushing of skin, and low blood pressure
- Infections due to weakened immune system
The most common side effects include:
- headache, feeling tired, urinary tract infection, joint pain, lung infection, nausea, depression, pain in your arms and legs, diarrhea, vaginitis, rash, nose and throat infection, and stomach-area pain
Tysbari can also cause PML or progressive multifocal leukoencephalopathy which can lead to death or severe disability. PML is especially dangerous because there is no known treatment for it. The risk of getting PML increases if you have been infected with JCV because it can cause PML if you have a weakened immune system which happens when taking an immunosuppresor such as Tysbari.
You cannot take Tisbari if you have an already weakened immune system because of conditions such as HIV, AIDS, leukemia, lymphoma, or had an organ transplant. Tysabari can also cause harm the baby’s of breast-feeding women.
PML and meningitis have severe effects in relation to MS because they both target the brain. PML causes progressive damage and inflammation of the white matter in the brain. Meningitis targets the membranes that cover the brain and the spinal chord. Both of these side effects can progress the nerve damage done by MS, and is a risk which should be considered when taking this medication. Additionally, a patient should not take this immunosuppressor medication if they have an already weakened immune system because they are more susceptible to infections that can progress the damage causes by MS and/or add additional health concerns to the patient.








